��ɫ��

��ɫ��

Donate To Research Join The AAN

Events

Resources For

Abstract Details

Title Inhibition of FGFR1/2 decreases oligodendrocyte proliferation through ERK signaling in vitro

Topic Multiple Sclerosis

Presentation(s) P1 - (-)

Poster/Presentation
Number 398

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Vinothkumar Rajendran (Justus-Liebig University) PRESENTER	Mr. Rajendran has nothing to disclose.
Ranjithkumar Rajendran (Justus Liebig University)	Mr. Rajendran has nothing to disclose.
Martin Berghoff, MD, FAAN (BundeswehrZentralkrankenhaus Koblenz)	Dr. Berghoff has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen Idec. Dr. Berghoff has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Berghoff has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Berghoff has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MerckSerono. Dr. Berghoff has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squibb.